Nouvelle déclaration d'incident
No de la demande: 2021-5888
Numéro de référence du titulaire d'homologation: 2021-CA-000036
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G 5L3
Incident chez un animal domestique
Pays: CANADA
État: ONTARIO
ARLA No d'homologation 31368 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Zodiac Spot On II Smart Shield Flea Control for Cats and Kittens
Oui
Unités: mL
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair Cat
1
Femme
1
Inconnu
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
<=30 min / <=30 min
Système
Unknown / Inconnu
Non
Non
Unknown/Inconnu
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 03 March 2021 the animal owner applied the product topically to the cat. Immediately after application the cat developed aggressive behaviour. The cat then ran away from the animal owners and went into the basement; the cat was confined in the basement overnight. On the morning of 04 March 2021 the cat was released from the basement and the cat developed application site pruritus as well as aggressive behaviour. Cat was confined to the basement again. Bathing the cat was discussed with the animal owner, but only if it could be performed with no risk of injury to people or the cat. No further information is expected.
Modérée
(S)-Methoprene and the other ingredients in this product have a wide margin of safety. There is risk of irritation including dermal, ocular (if ocular contact had occurred), and GI (if ingested). Pruritus may occur due to dermal irritation or because of the presence of fleas. Discomfort may develop when dermal irritation occurs and some cats could manifest this discomfort as aggression, however direct development of aggression due to this products use is not expected. Hiding behaviour may also be a manifestation of discomfort due to dermal irritation. Other causes including stress during handling for product application, trauma, or underlying causes should also be considered. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.